EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSLACG00000006548
Gene Symbol: DHCR24
4 Cross references
208 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSLACG00000009121
Gene Symbol: HMGCR
3 Cross references
270 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSLACG00000002897
Gene Symbol: PDPK1
4 Cross references
243 Possible Orthologues:

40s Ribosomal Protein S12-Like

Ensembl ID : ENSLACG00000007660
Gene Symbol: LOC102345094
4 Cross references
176 Possible Orthologues:

40s Ribosomal Protein S13

Ensembl ID : ENSLACG00000009755
Gene Symbol: LOC102360432
4 Cross references
64 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSLACG00000009018
Gene Symbol: NT5E
2 Cross references
248 Possible Orthologues:

5-Hydroxytryptamine Receptor 1a

Ensembl ID : ENSLACG00000002267
Gene Symbol: HTR1A
4 Cross references
147 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSLACG00000004131
Gene Symbol: HTR1B
4 Cross references
245 Possible Orthologues:

5-Hydroxytryptamine Receptor 1e

Ensembl ID : ENSLACG00000005227
Gene Symbol: HTR1E
4 Cross references
155 Possible Orthologues:

5-Hydroxytryptamine Receptor 2a

Ensembl ID : ENSLACG00000001141
Gene Symbol: HTR2A
4 Cross references
218 Possible Orthologues:

5-Hydroxytryptamine Receptor 2b

Ensembl ID : ENSLACG00000001333
Gene Symbol: HTR2B
4 Cross references
203 Possible Orthologues:

5-Hydroxytryptamine Receptor 2c

Ensembl ID : ENSLACG00000002608
Gene Symbol: HTR2C
4 Cross references
225 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).